These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20130739)

  • 1. Role of glucagon-like peptide-1 analogues on insulin receptor regulation in diabetic rat hearts.
    Hantouche CM; Bitar KM; Nemer GM; Obeid MY; Kadi LN; Der-Boghossian AH; Bikhazi AB
    Can J Physiol Pharmacol; 2010 Jan; 88(1):54-63. PubMed ID: 20130739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glucagon-like peptide-1 and its agonists on early prevention of cardiac remodeling in type 1 diabetic rat hearts.
    Barakat GM; Nuwayri-Salti N; Kadi LN; Bitar KM; Al-Jaroudi WA; Bikhazi AB
    Gen Physiol Biophys; 2011 Mar; 30(1):34-44. PubMed ID: 21460410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts.
    Maharsy WM; Kadi LN; Issa NG; Bitar KM; Der-Boghossian AH; Abrahamian R; Bikhazi AB
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):59-65. PubMed ID: 17703431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aliskiren, exendin-4, and insulin: their impact on endothelin receptor subtype(s) regulation/binding in type 1 diabetic rat hearts.
    Al Lafi SM; Artinian SB; Boutary SS; Zwainy NS; Bitar KM; Bikhazi AB
    Can J Physiol Pharmacol; 2013 Oct; 91(10):830-8. PubMed ID: 24144054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of systemic insulin and angiotensin II receptor subtype-1 antagonist on endothelin-1 receptor subtype(s) regulation and binding in diabetic rat heart.
    Karam CN; Nuwayri-Salti N; Usta JA; Zwainy DS; Abrahamian RE; Al Jaroudi WA; Baasisri MJ; Abdallah SM; Bitar KM; Bikhazi AB
    Endothelium; 2005; 12(5-6):225-31. PubMed ID: 16410221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
    Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium and myocyte cellular insulin receptor alterations in a rat model of myocardial infarction.
    Jaroudi WA; Jurjus AR; El-Sabban ME; Kamal MT; Bitar KM; Bikhazi AB
    Can J Physiol Pharmacol; 2003 Mar; 81(3):267-73. PubMed ID: 12733825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of GLP-1 receptor in type 1 diabetic rat hearts.
    Artinian SB; Al Lafi SM; Boutary SS; Bitar KM; Zwainy NS; Bikhazi AB
    Exp Diabetes Res; 2011; 2011():489708. PubMed ID: 21747829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin on jejunal PepT1 expression and function regulation in diabetic male and female rats.
    Der-Boghossian AH; Saad SR; Perreault C; Provost C; Jacques D; Kadi LN; Issa NG; Sibai AM; El-Majzoub NW; Bikhazi AB
    Can J Physiol Pharmacol; 2010 Jul; 88(7):753-9. PubMed ID: 20651823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
    Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
    Irwin N; McClean PL; Flatt PR
    J Pept Sci; 2007 Jun; 13(6):400-5. PubMed ID: 17486662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats.
    Park S; Hong SM; Sung SR
    Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin.
    Yang J; Campitelli J; Hu G; Lin Y; Luo J; Xue C
    Life Sci; 2007 Jul; 81(4):272-9. PubMed ID: 17583752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability.
    Youn YS; Chae SY; Lee S; Jeon JE; Shin HG; Lee KC
    Biochem Pharmacol; 2007 Jan; 73(1):84-93. PubMed ID: 17054919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment.
    Shirai M; Yamanaka M; Shiina H; Igawa M; Ogishima T; Fujime M; Ishii N; Okuyama A; Lue TF; Dahiya R
    Urology; 2004 Dec; 64(6):1244-9. PubMed ID: 15596216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
    Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
    Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats.
    Yu YL; Lu SS; Yu S; Liu YC; Wang P; Xie L; Wang GJ; Liu XD
    J Ethnopharmacol; 2009 Jul; 124(3):444-9. PubMed ID: 19497359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.